Search NEL Online

Journal Article 2012; 33(2): 138-148 PubMed PMID: 22592194 Citation  Keywords:  Animals, Body Weight:drug effects, Estradiol:blood, Female, Follicle Stimulating Hormone:blood, Gonadotrophs:drug effects, Gonadotropin-Releasing Hormone:blood, Growth Hormone:blood, Hypothalamus:drug effects, Insulin-Like Growth Factor I:metabolism, Lept.   

OBJECTIVE: Available data suggest that estrogens and leptin play a role in the control of the pubertal process. In humans and some mammal species the increase of the activity of gonadotropic axis accompanies the decrease in the rate of growth at puberty. The effect of 17β-estradiol and/or leptin administration on the somatotropic and gonadotropic axes was studied using prepubertal female rats as an animal model.

MATERIAL AND METHODS: Prepubertal female rats received estradiol/saline, estradiol/leptin, oil/leptin or oil/saline (vehicles) respectively. The changes of growth rate, and serum 17β-estradiol, leptin, GH, IGF-I and gonadotropins levels as well as LHRH and estrogen receptor (ER) concentrations in the medial basal hypothalamus (MBH) and the pituitary were determined. All hormones concentrations were measured by radioimmunoassay and ER by radioligand methods .

RESULTS: In estradiol and/or leptin treated animals noticeable reduction of rate of growth was found. The decrease of growth in response to estradiol treatment accompanied the increase GH level and the decrease of IGF-I concentration in the circulation. Both hormones operating together activated reproductive axis, what was manifested by a significant increase of LHRH abundant in the hypothalamus as well as elevated LH and FSH levels in the circulation. In these rats a significant decrease of the estrogen receptor concentrations in the pituitary was observed.

CONCLUSION: The role of estradiol and leptin in the control of growth and reproduction seems to overlap only partially. Estradiol plays a significant role in the activation of the reproductive axis, and leptin takes part as a permissive factor in pubertal process....

Read abstract  Full text PDF

Journal Article 2011; 32(6): 769-773 PubMed PMID: 22286790 Citation  Keywords:  Animals, Cells, Cultured, Estradiol:pharmacology, Female, Follicle Stimulating Hormone:secretion, Intracellular Signaling Peptides and Proteins:metabolism, Luteinizing Hormone:secretion, Neuropeptides:metabolism, Orexins, Ovariectomy, Pituitary Gland:cyto.   

OBJECTIVES: Orexin A (OxA) is a regulatory neuropeptide which is involved in the control of various autonomic and neuroendocrine functions. It regulates sleep-wake cycle, food intake and modulates the hypothalamic and pituitary hormones secretion. Orexin A acts through two types of receptors, which proved to exist in the pituitary. This may indicate the possibility of direct action of OxA on the adenohypophysis level. The aim of this study was to evaluate the direct effect of orexin A on gonadotropin (LH and FSH) release from cultured pituitary cells of immature female rats as well as mature female rats (ovariectomized and ovariectomized and estradiol treated rats).

MATERIAL AND METHODS: The effect of 0.1 nM and 100 nM orexin A on LH and FSH release from anterior pituitary cells after 1 h of incubation was examined in immature female rats (IM) as well as mature female (ovariectomized - M/OVX; and ovariectomized and estradiol treated - M/OVX+E2) rats. The concentration of LH and FSH in medium was determined by RIA method.

RESULTS: Orexin A at a dose of 0.1 nM and 100 nM significantly stimulated LH secretion in IM group. In M/OVX group release of LH was inhibited by OxA only in higher dose (100 nM). No effect of orexin A on FSH secretion was found.

CONCLUSIONS: OxA may directly modulate LH secretion from cultured pituitary cells and it has the contradictory effect on LH release in immature and ovariectomized mature female rats....

Read abstract  Full text PDF

Journal Article 2011; 32(6): 811-815 PubMed PMID: 22286789 Citation  Keywords:  Animals, Behavior, Animal:physiology, Estradiol:pharmacology, Estrogens:pharmacology, Facial Pain:physiopathology, Female, Male, Ovariectomy, Pain Measurement, Pain Threshold:drug effects, RNA, Messenger:metabolism, Random Allocation, Rats, Rats, Sprague-.   

OBJECTIVES: P2X3 receptors are expressed in trigeminal ganglia (TG) and participate in the transduction of facial pain. However, the mechanisms underlying P2X receptor-mediated nociception at different estrogen levels has not been examined.

METHODS: In this study, female rats were randomly divided into sham-operated (sham), ovariectomized (OVX), and estrogen-treated groups. In each group, the facial mechanical pain threshold was tested and the TG were harvested for a real-time PCR analysis of P2X3 receptor mRNA and western blot analysis of protein level.

RESULTS: In OVX rats we found that the mechanical pain threshold was significantly decreased compared with that in sham rats. Estrogen replacement reversed the decrease. The expression of P2X3 mRNA level in TG from OVX rats was significantly increased, consistent with the enhanced P2X3 receptor in protein level. Estrogen replacement could decrease the expression of P2X3 receptor in both mRNA and protein level.

CONCLUSION: These results indicate that estrogen might modulate the transduction of facial pain by inhibiting P2X3 receptor in TG....

Read abstract  Full text PDF

Journal Article 2011; 32(6): 857-864 PubMed PMID: 22286784 Citation  Keywords:  Adult, Body Mass Index, Estradiol:blood, Female, Human Growth Hormone:blood, Humans, Insulin-Like Growth Factor Binding Protein 3:blood, Insulin-Like Growth Factor I:metabolism, Young Adult,.   

OBJECTIVE: To compare the influence of low and normal endogenous estradiol concentration on circulating hGH, IGF-I and IGFBP-3 levels as well as on mutual correlations of these parameters.

PATIENTS: 45 women (age 30.7 ± 9.0 years, BMI 25.7 ± 8.0) divided into group A - 15 hypoestrogenic women and group B - 30 normoestrogenic controls. Neither of the women was menopausal nor hyperprolactinemic.

METHODS: Blood sample was taken at the standard conditions prior to the initiation of hormonal supplementation therapy in group A and at the day 3-5 of menstrual cycle in group B. Serum hGH, IGF-I, IGFBP-3, insulin, testosterone, sex hormone binding globulin (SHBG) dihydroepiandrosterone sulphate (DHEAS) and LH as well as prolactin (PRL), FSH and estradiol levels were measured by standard RIA kits.

RESULTS: Mean IGF-1, LH, FSH, testosterone and estradiol and PRL plasma levels were lower in group A compared to group B. There were no significant differences in mean SHBG, insulin and DHEAS levels. There were also no differences in mean: age, body mass, BMI as well as percentage of each BMI range between groups. Regardless the estradiol level the IGF-I/age link was found in both groups. A IGF-I/IGFBP-3 relation was found in both groups. IGF-I/estradiol link was seen only in group A. In group B hGH/SHBG link was found, in group A this relation was indirect. A link between hGH and testosterone levels was found only in group B. SHBG was related in group B to IGFBP-3, testosterone and to DHEAS. Insulin/IGFBP-3 link was seen in group B. The stepwise multiple regression revealed DHEAS and LH as predictors of IGF-I level in group A, while in group B none of the parameters predicted IGF-I level. The results of the same analysis in case of hGH are as follows: in group A hGH level was predicted by estradiol and SHBG. In group B none of factors predicted hGH levels.

CONCLUSION: Estradiol plasma level is correlated to circulating IGF-I, albeit the relation seems to be biphasic....

Read abstract  Full text PDF

Journal Article 2011; 32(5): 697-703 PubMed PMID: 22167129 Citation  Keywords:  Adolescent, Adrenal Glands:physiology, Adrenocorticotropic Hormone:blood, Anorexia Nervosa:metabolism, Child, Endocrine System:physiology, Estradiol:blood, Female, Follicle Stimulating Hormone:blood, Hormones:blood, Humans, Hydrocortisone:blood, Hypothala.   

OBJECTIVES: Thyroid, adrenal glands and gonadal hormones play a role in maintaining metabolic homeostasis of the body via the receptors located in the adipose tissue. The correlations between serum resistin (RES) and function of other hormonal axes in patients with AN have not been established, yet. Therefore, the aim of this study is: 1) assessment of concentrations of thyroid hormones (FT4, TSH), adrenal hormones (ACTH, cortisol), sex hormones (LH, FSH, estradiol, testosterone); 2) establishing their relationship with BMI and 3) analysis of correlations between examined hormones and RES serum concentrations in adolescent female patients with AN.

DESIGN AND SETTING: Serum RES (ELISA) and fT4, TSH, ACTH, LH, FSH, estradiol and testosterone (ECLIA) concentrations have been assayed in 195 adolescent girls: 87 with restrictive AN, 17 with not otherwise specified eating disorders (NOS), 30 with simple obesity (OB) and 61 healthy (H) subjects.

RESULTS: Mean serum FT4, LH and estradiol concentrations were significantly lower (p=0.015; p<0.0001; p<0.0001, respectively) in AN than in OB group, and cortisol increased (p<0.001) compared to OB and H subjects. In all examined subjects BMI correlated positively (p<0.0001) with LH (r=0.61) and estradiol (r=0.30), and negatively with cortisol (r=-0.35; p=0.008). Also the significant positive relationship between serum RES and FT4 (r=0.34), LH (r=0.57) as well as estradiol (r=0.28) was observed, whereas serum cortisol correlated negatively with RES (r=-0.40).

CONCLUSION: Changes in resistin serum concentrations in eating disorders may be involved in the altered regulation of hypothalamic-pituitary-adrenal, thyroid and gonadal axes....

Read abstract  Full text PDF

Journal Article 2011; 32(3): 340-344 PubMed PMID: 21670727 Citation  Keywords:  Administration, Cutaneous, Cell Adhesion Molecules:blood, Cholesterol:blood, Climacteric, Dose-Response Relationship, Drug, Dydrogesterone:administration & dosage, Endothelial Cells:drug effects, Estradiol:administration & dosage, Estrogen Replacement The.   

OBJECTIVE: In current literature, the immune-inflammatory theory of atherosclerosis is widely discussed. The role of how adhesion molecules contribute to the development of atheromatic plaques is especially underlined.

MATERIAL AND METHODS: 120 females in menopausal age were included in the study between 2004 and 2009. All the women were of menopausal age (51±3 years), from southern Poland, with FSH levels above 30 mIU/ml, and complaining of menopausal symptoms that disturbed normal daily activity. The study was conducted over a 6 month period. Three groups of 40 randomized patients were selected. The control group consisted of 40 volunteers, who were also from southern Poland, in good health, without menopausal symptoms, or menstrual periods in the last 6 months. Control subjects were match according to age and weight, with FSH levels above 25 mIU/ml and normal TSH and prolactin values. All patients, in the treatment and control groups were seronegative for Chlamydia pneumonia throughout the duration of the study.

RESULTS: After 6 months, hormonal therapy was found to significantly reduce levels of sICAM-1 and sVCAM-1 in all treated groups compared to the control group and the results were statistically significant. Alternatively, in the latter group, we observed increased levels of the investigated adhesion molecules (group I: 37.5 µg/24h transdermal estradiol + dydrogesteron; group II 50 µg/24h transdermal estradiol + medroxyprogesteron; group III 1mg of oral estradiol + noretisteron sICAM-1 and control group; using paired Wilcoxon test).

CONCLUSION: All of the investigated estrogen therapy schemas have a favorable impact on the blood levels of sICAM-1 and sVCAM-1 in postmenopausal women without cardiovascular risk factors, reducing their concentration....

Read abstract  Full text PDF

Journal Article 2010; 31(6): 775-781 PubMed PMID: 21196911 Citation  Keywords:  Adult, Aged, Depression:psychology, Female, Health Knowledge, Attitudes, Practice, Humans, Hyperthyroidism:psychology, Informed Consent:statistics & numerical data, Iodine Radioisotopes:therapeutic use, Male, Middle Aged, Patients:psychology, Poland, Surv.   

OBJECTIVES: Many patients with a chronic disease are dissatisfied with the information they are given. A brief questionnaire completed by patients would assist health professionals to identify areas of information needed to be provided, tailored to the patient's mental condition.

AIM: The aim of our study was to assess how often thyroid patients report being adequately informed about iodine treatment in connection with their real need thereof, emotional state and acceptance of the disease.

METHODS: One hundred outpatients who had presented subclinical hyperthyroidism "[19 men (19%), 81 women (81%); mean (SD±) age 53±14,range 18-77 yr ] treated with radioiodine (RAI) responded to an Experimental Questionnaire, 54 of them answered to AIS, HADS-M and Beck Inventory measuring their acceptance of the illness and depressive symptoms, 37 of them answered the Patient Request Form (PRF).

RESULTS: The obtained results indicated that about 50% of patients treated with 131I therapy did not receive suitable information about their treatment. Neither written information prepared by the specialist, nor verbal information given by physicians were adequate for specific problems of study group. The examined patients presented with a comparable intensity of three distinct types of requests: for explanation and reassurance, for emotional support, and for investigation and treatment. The acceptance of their disease was mediocre for most of the study group.

CONCLUSION: We conclude that the reported lack of satisfaction with medical information in study group was associated with depressive symptoms influencing cognitive efficiency, patients' great need of emotional and cognitive support, influencing the acceptance of their disease, and social prejudice to radioiodine (as a method of treatment), worrying them additionally. All thyroid patients even these with subclinical symptoms of hyperthyroidism should be treated with specific attention by physicians, especially during information process....

Read abstract  Full text PDF

Journal Article 2010; 31(Suppl 2): 51-56 PubMed PMID: 21187838 Citation  Keywords:  Adenocarcinoma:metabolism, Caco-2 Cells, Carbon Radioisotopes, Cell Membrane Permeability:drug effects, Cell Survival:drug effects, Colonic Neoplasms:metabolism, Dose-Response Relationship, Drug, Escherichia coli, Humans, Lipopolysaccharides:pharmacology,.   

OBJECTIVES: Different probiotic strains used in clinical trials have shown prophylactic properties in different inflammatory diseases of the gastrointestinal tract. This study was aimed to investigate the influence of Escherichia coli strain Nissle 1917 (EcN) components on the integrity of the Caco-2 cell monolayer (human adenocarcinoma cell line).

METHODS: The effect of supernatant of EcN suspension and lipopolysaccharide (LPS) isolated from EcN (in concentrations from 0.001 to 1 000 µg/ml) on paracellular transport of 14C-mannitol marker through epithelial cell monolayer was estimated.

RESULTS: Both LPS and EcN supernatant exerted almost the same effect; whereas no effect was shown using high concentrations (100 and 1 000 µg/ml), low concentrations (0.001, 0.1 and 1 µg/ml) significantly decreased permeability of 14C-mannitol. Concentration (0.001 µg/ml) decreased 14C-mannitol permeability approximately about 20% (LPS) and 30% (EcN supernatant). To elucidate the observed changes in monolayer permeability ("tighter monolayer") induced by concentrations of LPS or supernatant, media able to open epithelial intercellular junctions were used. The effects of Ca2+-free transport medium and of medium containing 5, 10, 20, 50, and 100% of Ca2+ on the 14C-mannitol transport in the presence of the lowest (0.001 µg/ml) and high (100 µg/ml) concentrations of LPS were studied. Using Ca2+-free medium both concentrations of LPS significantly decreased apparent permeability coefficient (Papp) of 14C-mannitol indicating that changes of 14C-mannitol permeability are independent of dimensions of paracellular spaces.

CONCLUSION: The decrease of 14C-mannitol permeability caused by EcN LPS indicates the ability of components of probiotic EcN strain to restore disrupted epithelial barrier....

Read abstract  Full text PDF